Multi-cancer early detection blood test that screens for 50+ cancers with a single draw.
The Galleri test is an advanced multi-cancer early detection (MCED) blood test designed to identify cancer signals before symptoms appear.
Screens for 50+ cancer types, including many without routine screening options
Uses cell-free DNA technology to detect cancer signals in the bloodstream
Can indicate the likely tissue of origin if a signal is found
Designed for proactive, preventive health strategies
Most screenings detect late-stage disease. This test identifies early cancer signals.
Adults seeking proactive cancer screening, especially those over 40 or with increased risk factors.
No. It complements, not replaces standard screening guidelines.
Typically within 2–3 weeks.
This is a concierge preventive test and may not be covered by insurance.